Newsroom
Sorted by: Latest
-
Phoenix Energy CEO Adam Ferrari's $15,000 Scholarship Advances to Finalist Review
IRVINE, Calif.--(BUSINESS WIRE)--Phoenix Energy One, LLC ("Phoenix Energy") has begun the finalist selection process for the 2026 Phoenix Energy Scholarship, a $15,000 award established by Phoenix Energy CEO Adam Ferrari to support the next generation of leaders in the American oil and gas industry. With the application period now closed, the Scholarship Committee is reviewing submissions and will select three finalists before announcing this year's recipient on September 1. Now in its fourth y...
-
Balyasny Asset Management LP UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Balyasny Asset Management L.P. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be...
-
Patelco Credit Union Invests in Payfinia CUSO, Joins Board to Shape the Future of Embedded Payments
PORTLAND, Ore.--(BUSINESS WIRE)--Payfinia, an independent payment services firm providing an open payments framework, today announced a strategic partnership with Dublin, Calif.-based Patelco Credit Union (‘Patelco’ – $9.5 billion in assets and more than 550,000 members), marked by the credit union’s investment* in the Payfinia Credit Union Service Organization (CUSO). As part of the partnership, Patelco’s Chief Technology Officer, Kal Majmundar, has joined the Payfinia CUSO Board of Directors,...
-
Niagen Bioscience Selects Global Drug Development Pioneer Evotec to Advance Preclinical Development for NB4168
LOS ANGELES--(BUSINESS WIRE)--Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced that it has selected Evotec (NASDAQ: EVO; Frankfurt Prime Standard: EVT), a global life science company specializing in drug discovery and development, as a contract research organization to support the advancement of NB4168. The work will be conducted in collaboration with NAD Pharmaceuticals Corp., N...
-
NATIXIS UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Boise Cascade and James Hardie Expand U.S. Nationwide Distribution Partnership
BOISE, Idaho & CHICAGO--(BUSINESS WIRE)--Boise Cascade Company (“Boise Cascade”) (NYSE: BCC) and James Hardie Building Products Inc. (“James Hardie”), a wholly-owned subsidiary of James Hardie Industries plc (“JHI”) (NYSE / ASX: JHX), today announced an expansion of their partnership under which Boise Cascade’s Building Materials Distribution division will become the sole nationwide distributor of James Hardie’s and its North American affiliates’ complete portfolio of exterior building products...
-
NATIXIS UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: NATIXIS SA (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. (c) Name o...
-
Adagio Medical Treats First Patient with Faster, Single-Freeze Next-Generation ULTA System
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced the successful treatment of the first patient with its next-generation vCLAS Ultra Ultra-Low Temperature Ablation (“ULTA”) system under Expanded Access authorization from the U.S. Food and Drug Administration (“FDA”).The patient, who presented with non-ischemic cardiomyopath...
-
Deep Fission CEO Liz Muller to Present at Canaccord Genuity’s 46th Annual Growth Conference
BERKELEY, Calif.--(BUSINESS WIRE)--Deep Fission, Inc. (Nasdaq: FISN) (“Deep Fission” or the “Company”), an advanced nuclear energy company developing small modular pressurized water reactors deployed one mile underground, today announced that Liz Muller, Co-Founder and CEO of Deep Fission, will present at Canaccord Genuity’s 46th Annual Growth Conference in Boston, MA on Tuesday, August 11, 2026 at 1:30 p.m. ET. Investors can register for the live webcast of the presentation HERE. In addition,...
-
Sony Pictures’ Spider-Man: Brand New Day to Expand in IMAX® Across North America Beginning August 6
NEW YORK--(BUSINESS WIRE)--IMAX® Corporation (NYSE: IMAX) today announced that Sony Pictures’ Spider-Man: Brand New Day will expand across the IMAX network into North America beginning Thursday, August 6. The move follows a strong IMAX opening for the film in China, Japan and South Korea, where it generated $23 million at the IMAX box office. In China, the film earned $19 million in IMAX, delivering the biggest IMAX opening weekend in Spider-Man franchise history, while accounting for a franchi...